Zobrazeno 1 - 10
of 14
pro vyhledávání: '"Jenny L. Schnyder"'
Autor:
Jenny L. Schnyder, Federico Gobbi, Mirjam Schunk, Andreas Lindner, Fernando Salvador, Alexandre Duvignaud, Marta Arsuaga Vicente, Jean Claude Dejon Agobé, Paolo Cattaneo, Giulia Bertoli, Camilla Rothe, Mia Wintel, Diana Pou, Denis Malvy, Ayola Akim Adegnika, Hanna K. De Jong, Martin P. Grobusch
Publikováno v:
New Microbes and New Infections, Vol 53, Iss , Pp 101136- (2023)
Background: Earlier studies found characteristic haematological changes in African patients with active schistosomiasis. If consistently present, full blood counts (FBC) may be helpful to diagnose schistosomiasis also in migrants and returning travel
Externí odkaz:
https://doaj.org/article/36f75a9cd0404ce494b11f96ba07edb9
Autor:
Hannah M.Garcia Garrido, Jenny L. Schnyder, Michael W.T. Tanck, Albert Vollaard, René Spijker, Martin P. Grobusch, Abraham Goorhuis
Publikováno v:
EClinicalMedicine, Vol 29, Iss , Pp 100576- (2020)
Background: The objective of this systematic review and meta-analysis was to summarise the literature regarding the immunogenicity of pneumococcal conjugate vaccines (PCV) and pneumococcal polysaccharide vaccines (PPSV) in adult people living with HI
Externí odkaz:
https://doaj.org/article/95ac6ef3d3b846b5bb203ee6564bb9e0
Autor:
Martin P. Grobusch, Leisa Weld, Jenny L. Schnyder, Carsten Schade Larsen, Andreas K. Lindner, Corneliu Petru Popescu, Ralph Huits, A. Goorhuis, Philippe Gautret, Patricia Schlagenhauf
Publikováno v:
Travel medicine and infectious disease, 53:102583. Elsevier USA
Travel Medicine and Infectious Disease
Travel Medicine and Infectious Disease, 2023, 53, pp.102583. ⟨10.1016/j.tmaid.2023.102583⟩
Travel Medicine and Infectious Disease
Travel Medicine and Infectious Disease, 2023, 53, pp.102583. ⟨10.1016/j.tmaid.2023.102583⟩
Background: The COVID-19 pandemic resulted in a sharp decline of post-travel patient encounters at the European sentinel surveillance network (EuroTravNet) of travellers’ health. We report on the impact of COVID-19 on travel-related infectious dise
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::883e5c0d7acebcd1d252a5361fc0ae47
https://pure.amc.nl/en/publications/covid19-impact-on-eurotravnet-infectious-diseases-sentinel-surveillance-in-europe(e0b1e15d-5b8b-4104-b0f5-c7155d9d7fba).html
https://pure.amc.nl/en/publications/covid19-impact-on-eurotravnet-infectious-diseases-sentinel-surveillance-in-europe(e0b1e15d-5b8b-4104-b0f5-c7155d9d7fba).html
Autor:
Jenny L. Schnyder, Hanna K. de Jong, Emmanuel B. Bache, Reinier M. van Hest, Patricia Schlagenhauf, Steffen Borrmann, Thomas Hanscheid, Martin P. Grobusch
Publikováno v:
Travel medicine and infectious disease, 52:102520. Elsevier USA
According to current guidelines, atovaquone-proguanil (AP) malaria chemoprophylaxis should be taken once daily starting one day before travel and continued for seven days post-exposure. However, drug-sparing regimens, including discontinuing AP after
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::295ba4f5f2e0e7a18d8e735e2aa51d9e
https://pure.amc.nl/en/publications/on-the-potential-for-discontinuing-atovaquoneproguanil-ap-adhoc-postexposure-and-other-abbreviated-apregimens(8cc2ac8f-ee7d-419a-9950-fd1575ef22b0).html
https://pure.amc.nl/en/publications/on-the-potential-for-discontinuing-atovaquoneproguanil-ap-adhoc-postexposure-and-other-abbreviated-apregimens(8cc2ac8f-ee7d-419a-9950-fd1575ef22b0).html
Publikováno v:
Clinical microbiology and infection, 28(1), 6-8. Elsevier Limited
Clinical Microbiology and Infection
Clinical Microbiology and Infection
Autor:
Hannah M. Garcia Garrido, Jenny L. Schnyder, Beheshta Haydari, Albert M. Vollaard, Michael W.T. Tanck, Godelieve J. de Bree, Bob Meek, Martin P. Grobusch, Abraham Goorhuis
Publikováno v:
International Journal of Antimicrobial Agents, 60(2):106629. Elsevier
International journal of antimicrobial agents, 60(2):106629. Elsevier
Garcia Garrido, H M, Schnyder, J L, Haydari, B, Vollaard, A M, Tanck, M W T, de Bree, G J, Meek, B, Grobusch, M P & Goorhuis, A 2022, ' Immunogenicity of the 13-valent pneumococcal conjugate vaccine followed by the 23-valent pneumococcal polysaccharide vaccine in people living with HIV on combination antiretroviral therapy ', International Journal of Antimicrobial Agents, vol. 60, no. 2, 106629 . https://doi.org/10.1016/j.ijantimicag.2022.106629
International journal of antimicrobial agents, 60(2):106629. Elsevier
Garcia Garrido, H M, Schnyder, J L, Haydari, B, Vollaard, A M, Tanck, M W T, de Bree, G J, Meek, B, Grobusch, M P & Goorhuis, A 2022, ' Immunogenicity of the 13-valent pneumococcal conjugate vaccine followed by the 23-valent pneumococcal polysaccharide vaccine in people living with HIV on combination antiretroviral therapy ', International Journal of Antimicrobial Agents, vol. 60, no. 2, 106629 . https://doi.org/10.1016/j.ijantimicag.2022.106629
People living with HIV (PLWH) are at increased risk of pneumococcal infections compared with the general population. The objective of this study was to investigate the immunogenicity of the combined pneumococcal vaccination schedule in PLWH. In this
Autor:
Jenny L. Schnyder, Hanna K. de Jong, Patricia Schlagenhauf, Steffen Borrmann, Thomas Hanscheid, Martin P. Grobusch
Publikováno v:
Travel Medicine and Infectious Disease. 49:102365
© 2022 The Authors. Published by Elsevier Ltd. This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/)
Background: Atovaquone/proguanil (AP) is a highly effective malaria chemoprophylaxis combination
Background: Atovaquone/proguanil (AP) is a highly effective malaria chemoprophylaxis combination
Autor:
Cornelis A. De Pijper, Joost G. Daams, Martin P. Grobusch, Cornelis Stijnis, Hannah M. Garcia Garrido, Abraham Goorhuis, Jenny L. Schnyder
Publikováno v:
Travel medicine and infectious disease. 41
Background For certain vaccines, dosing can be reduced by intradermal (ID) immunization without loss of immunogenicity, as an alternative to standard routes of administration. However, a certain level of dose-sparing might also be achieved by reducin
Autor:
Abraham Goorhuis, Michael W.T. Tanck, Jenny L. Schnyder, René Spijker, Albert M Vollaard, Hannah M. Garcia Garrido, Martin P. Grobusch
Publikováno v:
EClinicalMedicine, Vol 29, Iss, Pp 100576-(2020)
EClinicalMedicine, 29-30:100576. Lancet Publishing Group
EClinicalMedicine
EClinicalMedicine, 29-30:100576. Lancet Publishing Group
EClinicalMedicine
Background The objective of this systematic review and meta-analysis was to summarise the literature regarding the immunogenicity of pneumococcal conjugate vaccines (PCV) and pneumococcal polysaccharide vaccines (PPSV) in adult people living with HIV
Autor:
Jenny L. Schnyder, Hannah M. Garcia-Garrido, Abraham Goorhuis, Johanna J. Wisman, Martin P. Grobusch, Hanna K. de Jong, Thomas Hänscheid, Cornelis Stijnis
Publikováno v:
Travel Medicine and Infectious Disease
Travel medicine and infectious disease, 43:102093. Elsevier USA
Travel medicine and infectious disease, 43:102093. Elsevier USA